Interestingly, XNT treatment dose-dependently reduced CDK2 expression in the colon cancer cell HCT116 [54], suggesting CDK2 may be indirectly involved for XNT to display its broad antiviral activity. Here, CDK2 is linked to malignant colon neoplasm.